View in EDS PDF Full Text

The prevalence of anti-factor VIII and anti-factor IX antibodies among patients with hemophilia in Rabat, Morocco: a single center experience.

Saved in:
Bibliographic Details
Title: The prevalence of anti-factor VIII and anti-factor IX antibodies among patients with hemophilia in Rabat, Morocco: a single center experience.
Authors: Bouyadmar M; Department of Pediatrics, Cheikh Khalifa Ibn Zayed International University Hospital, Casablanca, Morocco.; Hemophilia Treatment Center and Bleeding Disorders, Hematology-Oncology Unit, Children's Hospital Rabat, Mohamed V University, Rabat, Morocco., Khorassani ME; Hemophilia Treatment Center and Bleeding Disorders, Hematology-Oncology Unit, Children's Hospital Rabat, Mohamed V University, Rabat, Morocco., Kababri ME; Hemophilia Treatment Center and Bleeding Disorders, Hematology-Oncology Unit, Children's Hospital Rabat, Mohamed V University, Rabat, Morocco., Kili A; Hemophilia Treatment Center and Bleeding Disorders, Hematology-Oncology Unit, Children's Hospital Rabat, Mohamed V University, Rabat, Morocco., Hessissen L; Hemophilia Treatment Center and Bleeding Disorders, Hematology-Oncology Unit, Children's Hospital Rabat, Mohamed V University, Rabat, Morocco.
Source: The Pan African medical journal [Pan Afr Med J] 2022 Feb 14; Vol. 41, pp. 126. Date of Electronic Publication: 2022 Feb 14 (Print Publication: 2022).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: African Field Epidemiology Network Country of Publication: Uganda NLM ID: 101517926 Publication Model: eCollection Cited Medium: Internet ISSN: 1937-8688 (Electronic) NLM ISO Abbreviation: Pan Afr Med J Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1937-8688
DOI:10.11604/pamj.2022.41.126.29571